nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.146	1	CrCrCtD
Methadone—CYP1A2—type 2 diabetes mellitus	0.126	0.602	CbGaD
Methadone—CYP3A4—type 2 diabetes mellitus	0.0834	0.398	CbGaD
Methadone—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0443	0.0966	CbGbCtD
Methadone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0165	0.0359	CbGbCtD
Methadone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0132	0.0287	CbGbCtD
Methadone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0125	0.0273	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0125	0.0273	CbGbCtD
Methadone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0125	0.0273	CbGbCtD
Methadone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0119	0.026	CbGbCtD
Methadone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0117	0.0256	CbGbCtD
Methadone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0115	0.0251	CbGbCtD
Methadone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0111	0.0243	CbGbCtD
Methadone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.011	0.024	CbGbCtD
Methadone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0106	0.0232	CbGbCtD
Methadone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0105	0.0229	CbGbCtD
Methadone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00999	0.0218	CbGbCtD
Methadone—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00999	0.0218	CbGbCtD
Methadone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00976	0.0213	CbGbCtD
Methadone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00938	0.0205	CbGbCtD
Methadone—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00922	0.0201	CbGbCtD
Methadone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0089	0.0194	CbGbCtD
Methadone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00865	0.0189	CbGbCtD
Methadone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0085	0.0186	CbGbCtD
Methadone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0083	0.0181	CbGbCtD
Methadone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0083	0.0181	CbGbCtD
Methadone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00806	0.0176	CbGbCtD
Methadone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00766	0.0167	CbGbCtD
Methadone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00759	0.0166	CbGbCtD
Methadone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00749	0.0164	CbGbCtD
Methadone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0074	0.0162	CbGbCtD
Methadone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00701	0.0153	CbGbCtD
Methadone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00677	0.0148	CbGbCtD
Methadone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00669	0.0146	CbGbCtD
Methadone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00668	0.0146	CbGbCtD
Methadone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00633	0.0138	CbGbCtD
Methadone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00629	0.0137	CbGbCtD
Methadone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00611	0.0133	CbGbCtD
Methadone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00603	0.0132	CbGbCtD
Methadone—CYP3A5—Losartan—type 2 diabetes mellitus	0.0058	0.0127	CbGbCtD
Methadone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00575	0.0126	CbGbCtD
Methadone—CYP2C8—Losartan—type 2 diabetes mellitus	0.00557	0.0122	CbGbCtD
Methadone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00554	0.0121	CbGbCtD
Methadone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00552	0.012	CbGbCtD
Methadone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00534	0.0117	CbGbCtD
Methadone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00511	0.0112	CbGbCtD
Methadone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00483	0.0105	CbGbCtD
Methadone—CYP2C19—Losartan—type 2 diabetes mellitus	0.00468	0.0102	CbGbCtD
Methadone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00431	0.00942	CbGbCtD
Methadone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00425	0.00928	CbGbCtD
Methadone—ABCB1—Glyburide—type 2 diabetes mellitus	0.00412	0.009	CbGbCtD
Methadone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00389	0.00849	CbGbCtD
Methadone—ABCB1—Losartan—type 2 diabetes mellitus	0.00377	0.00824	CbGbCtD
Methadone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00366	0.00799	CbGbCtD
Methadone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00351	0.00766	CbGbCtD
Methadone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00351	0.00766	CbGbCtD
Methadone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00332	0.00724	CbGbCtD
Methadone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00247	0.00539	CbGbCtD
Methadone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00226	0.00493	CbGbCtD
Methadone—HTR3A—nerve—type 2 diabetes mellitus	0.000365	0.112	CbGeAlD
Methadone—OPRM1—nerve—type 2 diabetes mellitus	0.000335	0.102	CbGeAlD
Methadone—Clotrimazole—CYP11A1—type 2 diabetes mellitus	0.000208	0.0791	CrCbGaD
Methadone—Loperamide—CALM1—type 2 diabetes mellitus	0.0002	0.076	CrCbGaD
Methadone—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000177	0.054	CbGeAlD
Methadone—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000176	0.0668	CrCbGaD
Methadone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000171	0.0523	CbGeAlD
Methadone—OPRD1—kidney—type 2 diabetes mellitus	0.000168	0.0514	CbGeAlD
Methadone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000146	0.0448	CbGeAlD
Methadone—Promethazine—CALM1—type 2 diabetes mellitus	0.000145	0.0549	CrCbGaD
Methadone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000125	0.00111	CcSEcCtD
Methadone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000124	0.00111	CcSEcCtD
Methadone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000124	0.00111	CcSEcCtD
Methadone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000124	0.0011	CcSEcCtD
Methadone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000123	0.0011	CcSEcCtD
Methadone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000123	0.00109	CcSEcCtD
Methadone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00109	CcSEcCtD
Methadone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000123	0.00109	CcSEcCtD
Methadone—Syncope—Metformin—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
Methadone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
Methadone—Oedema—Valsartan—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
Methadone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000122	0.00109	CcSEcCtD
Methadone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000122	0.00108	CcSEcCtD
Methadone—Rash—Glipizide—type 2 diabetes mellitus	0.000122	0.00108	CcSEcCtD
Methadone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
Methadone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
Methadone—Erythema—Losartan—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
Methadone—Oedema—Orlistat—type 2 diabetes mellitus	0.000121	0.00107	CcSEcCtD
Methadone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000121	0.00107	CcSEcCtD
Methadone—Headache—Glipizide—type 2 diabetes mellitus	0.000121	0.00107	CcSEcCtD
Methadone—Tremor—Irbesartan—type 2 diabetes mellitus	0.000121	0.00107	CcSEcCtD
Methadone—Palpitations—Metformin—type 2 diabetes mellitus	0.000121	0.00107	CcSEcCtD
Methadone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Methadone—Shock—Valsartan—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Methadone—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Methadone—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00012	0.00106	CcSEcCtD
Methadone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
Methadone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000119	0.00105	CcSEcCtD
Methadone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
Methadone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
Methadone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
Methadone—CYP2C18—liver—type 2 diabetes mellitus	0.000118	0.0359	CbGeAlD
Methadone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
Methadone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
Methadone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
Methadone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
Methadone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
Methadone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
Methadone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
Methadone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000116	0.00103	CcSEcCtD
Methadone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000115	0.00102	CcSEcCtD
Methadone—Clotrimazole—ABCC2—type 2 diabetes mellitus	0.000115	0.0435	CrCbGaD
Methadone—Nausea—Glipizide—type 2 diabetes mellitus	0.000115	0.00102	CcSEcCtD
Methadone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
Methadone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
Methadone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00101	CcSEcCtD
Methadone—Pain—Gliclazide—type 2 diabetes mellitus	0.000114	0.00101	CcSEcCtD
Methadone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000114	0.00101	CcSEcCtD
Methadone—Tremor—Losartan—type 2 diabetes mellitus	0.000114	0.00101	CcSEcCtD
Methadone—Rash—Glimepiride—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Methadone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Methadone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Methadone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000113	0.001	CcSEcCtD
Methadone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000113	0.001	CcSEcCtD
Methadone—Headache—Glimepiride—type 2 diabetes mellitus	0.000113	0.001	CcSEcCtD
Methadone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000112	0.000998	CcSEcCtD
Methadone—CYP3A7—liver—type 2 diabetes mellitus	0.000112	0.0342	CbGeAlD
Methadone—Agitation—Losartan—type 2 diabetes mellitus	0.000111	0.00099	CcSEcCtD
Methadone—Oedema—Metformin—type 2 diabetes mellitus	0.000111	0.00099	CcSEcCtD
Methadone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000986	CcSEcCtD
Methadone—Flushing—Ramipril—type 2 diabetes mellitus	0.000111	0.000984	CcSEcCtD
Methadone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000111	0.000983	CcSEcCtD
Methadone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00011	0.000975	CcSEcCtD
Methadone—Shock—Metformin—type 2 diabetes mellitus	0.00011	0.000974	CcSEcCtD
Methadone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000109	0.000971	CcSEcCtD
Methadone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000109	0.000971	CcSEcCtD
Methadone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000109	0.000971	CcSEcCtD
Methadone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000109	0.000969	CcSEcCtD
Methadone—Vertigo—Losartan—type 2 diabetes mellitus	0.000109	0.000968	CcSEcCtD
Methadone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000109	0.000967	CcSEcCtD
Methadone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000109	0.000966	CcSEcCtD
Methadone—Syncope—Losartan—type 2 diabetes mellitus	0.000109	0.000966	CcSEcCtD
Methadone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000108	0.000957	CcSEcCtD
Methadone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000953	CcSEcCtD
Methadone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000107	0.000953	CcSEcCtD
Methadone—Palpitations—Losartan—type 2 diabetes mellitus	0.000107	0.000952	CcSEcCtD
Methadone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000107	0.000949	CcSEcCtD
Methadone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000107	0.000948	CcSEcCtD
Methadone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000107	0.000947	CcSEcCtD
Methadone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000946	CcSEcCtD
Methadone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000106	0.000945	CcSEcCtD
Methadone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000106	0.000945	CcSEcCtD
Methadone—Anorexia—Metformin—type 2 diabetes mellitus	0.000106	0.000943	CcSEcCtD
Methadone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000106	0.00094	CcSEcCtD
Methadone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000105	0.000935	CcSEcCtD
Methadone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000105	0.000935	CcSEcCtD
Methadone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000105	0.000934	CcSEcCtD
Methadone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000105	0.000934	CcSEcCtD
Methadone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000105	0.000933	CcSEcCtD
Methadone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000105	0.000932	CcSEcCtD
Methadone—Constipation—Valsartan—type 2 diabetes mellitus	0.000105	0.000929	CcSEcCtD
Methadone—Hypotension—Metformin—type 2 diabetes mellitus	0.000104	0.000925	CcSEcCtD
Methadone—Erythema—Ramipril—type 2 diabetes mellitus	0.000104	0.000923	CcSEcCtD
Methadone—Shock—Irbesartan—type 2 diabetes mellitus	0.000103	0.000919	CcSEcCtD
Methadone—Pain—Orlistat—type 2 diabetes mellitus	0.000103	0.000918	CcSEcCtD
Methadone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000916	CcSEcCtD
Methadone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000914	CcSEcCtD
Methadone—Anxiety—Losartan—type 2 diabetes mellitus	0.000103	0.000914	CcSEcCtD
Methadone—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000912	CcSEcCtD
Methadone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000909	CcSEcCtD
Methadone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000908	CcSEcCtD
Methadone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000102	0.000903	CcSEcCtD
Methadone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000903	CcSEcCtD
Methadone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000102	0.000901	CcSEcCtD
Methadone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000101	0.000897	CcSEcCtD
Methadone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.0001	0.00089	CcSEcCtD
Methadone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.0001	0.000889	CcSEcCtD
Methadone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.0001	0.000888	CcSEcCtD
Methadone—Confusional state—Losartan—type 2 diabetes mellitus	9.98e-05	0.000886	CcSEcCtD
Methadone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000885	CcSEcCtD
Methadone—Somnolence—Metformin—type 2 diabetes mellitus	9.91e-05	0.00088	CcSEcCtD
Methadone—Oedema—Losartan—type 2 diabetes mellitus	9.9e-05	0.000879	CcSEcCtD
Methadone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.9e-05	0.000879	CcSEcCtD
Methadone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.89e-05	0.000878	CcSEcCtD
Methadone—Hypotension—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000873	CcSEcCtD
Methadone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000871	CcSEcCtD
Methadone—Tremor—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000865	CcSEcCtD
Methadone—Shock—Losartan—type 2 diabetes mellitus	9.74e-05	0.000865	CcSEcCtD
Methadone—Urticaria—Valsartan—type 2 diabetes mellitus	9.72e-05	0.000863	CcSEcCtD
Methadone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.69e-05	0.000861	CcSEcCtD
Methadone—Decreased appetite—Metformin—type 2 diabetes mellitus	9.69e-05	0.00086	CcSEcCtD
Methadone—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.68e-05	0.000859	CcSEcCtD
Methadone—Tachycardia—Losartan—type 2 diabetes mellitus	9.66e-05	0.000858	CcSEcCtD
Methadone—Nausea—Bromocriptine—type 2 diabetes mellitus	9.64e-05	0.000856	CcSEcCtD
Methadone—Urticaria—Orlistat—type 2 diabetes mellitus	9.61e-05	0.000853	CcSEcCtD
Methadone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.57e-05	0.00085	CcSEcCtD
Methadone—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.56e-05	0.000849	CcSEcCtD
Methadone—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.56e-05	0.000849	CcSEcCtD
Methadone—Asthenia—Gliclazide—type 2 diabetes mellitus	9.56e-05	0.000849	CcSEcCtD
Methadone—Agitation—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000849	CcSEcCtD
Methadone—Constipation—Metformin—type 2 diabetes mellitus	9.53e-05	0.000846	CcSEcCtD
Methadone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	9.51e-05	0.0291	CbGeAlD
Methadone—Anorexia—Losartan—type 2 diabetes mellitus	9.44e-05	0.000838	CcSEcCtD
Methadone—Vomiting—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000838	CcSEcCtD
Methadone—Pruritus—Gliclazide—type 2 diabetes mellitus	9.43e-05	0.000837	CcSEcCtD
Methadone—Rash—Glyburide—type 2 diabetes mellitus	9.35e-05	0.000831	CcSEcCtD
Methadone—Somnolence—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.00083	CcSEcCtD
Methadone—Dermatitis—Glyburide—type 2 diabetes mellitus	9.35e-05	0.00083	CcSEcCtD
Methadone—Vertigo—Ramipril—type 2 diabetes mellitus	9.34e-05	0.00083	CcSEcCtD
Methadone—Syncope—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000828	CcSEcCtD
Methadone—Headache—Glyburide—type 2 diabetes mellitus	9.29e-05	0.000825	CcSEcCtD
Methadone—Hypotension—Losartan—type 2 diabetes mellitus	9.25e-05	0.000821	CcSEcCtD
Methadone—Palpitations—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000816	CcSEcCtD
Methadone—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.18e-05	0.000816	CcSEcCtD
Methadone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000812	CcSEcCtD
Methadone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000812	CcSEcCtD
Methadone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.11e-05	0.000809	CcSEcCtD
Methadone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.11e-05	0.000809	CcSEcCtD
Methadone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.02e-05	0.000801	CcSEcCtD
Methadone—Convulsion—Ramipril—type 2 diabetes mellitus	9.01e-05	0.0008	CcSEcCtD
Methadone—Pain—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000799	CcSEcCtD
Methadone—Constipation—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000799	CcSEcCtD
Methadone—Insomnia—Losartan—type 2 diabetes mellitus	8.95e-05	0.000795	CcSEcCtD
Methadone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.91e-05	0.000791	CcSEcCtD
Methadone—Urticaria—Metformin—type 2 diabetes mellitus	8.85e-05	0.000786	CcSEcCtD
Methadone—Anxiety—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000783	CcSEcCtD
Methadone—Nausea—Glyburide—type 2 diabetes mellitus	8.81e-05	0.000782	CcSEcCtD
Methadone—Abdominal pain—Metformin—type 2 diabetes mellitus	8.81e-05	0.000782	CcSEcCtD
Methadone—Dizziness—Gliclazide—type 2 diabetes mellitus	8.81e-05	0.000782	CcSEcCtD
Methadone—Somnolence—Losartan—type 2 diabetes mellitus	8.8e-05	0.000781	CcSEcCtD
Methadone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	8.8e-05	0.0269	CbGeAlD
Methadone—Asthenia—Valsartan—type 2 diabetes mellitus	8.78e-05	0.00078	CcSEcCtD
Methadone—CYP19A1—adipose tissue—type 2 diabetes mellitus	8.68e-05	0.0265	CbGeAlD
Methadone—Asthenia—Orlistat—type 2 diabetes mellitus	8.68e-05	0.00077	CcSEcCtD
Methadone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.00077	CcSEcCtD
Methadone—Pruritus—Valsartan—type 2 diabetes mellitus	8.66e-05	0.000769	CcSEcCtD
Methadone—Dry mouth—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000769	CcSEcCtD
Methadone—Decreased appetite—Losartan—type 2 diabetes mellitus	8.6e-05	0.000764	CcSEcCtD
Methadone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.6e-05	0.000764	CcSEcCtD
Methadone—Confusional state—Ramipril—type 2 diabetes mellitus	8.56e-05	0.00076	CcSEcCtD
Methadone—Pruritus—Orlistat—type 2 diabetes mellitus	8.56e-05	0.00076	CcSEcCtD
Methadone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000754	CcSEcCtD
Methadone—Oedema—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000754	CcSEcCtD
Methadone—Vomiting—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000752	CcSEcCtD
Methadone—Pain—Losartan—type 2 diabetes mellitus	8.46e-05	0.000752	CcSEcCtD
Methadone—Constipation—Losartan—type 2 diabetes mellitus	8.46e-05	0.000752	CcSEcCtD
Methadone—Rash—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.000746	CcSEcCtD
Methadone—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000745	CcSEcCtD
Methadone—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000744	CcSEcCtD
Methadone—Oxaprozin—PTGS2—type 2 diabetes mellitus	8.37e-05	0.0318	CrCbGaD
Methadone—Urticaria—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000742	CcSEcCtD
Methadone—Shock—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000741	CcSEcCtD
Methadone—Headache—Gliclazide—type 2 diabetes mellitus	8.35e-05	0.000741	CcSEcCtD
Methadone—Benzphetamine—ADRA2A—type 2 diabetes mellitus	8.34e-05	0.0317	CrCbGaD
Methadone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000738	CcSEcCtD
Methadone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000738	CcSEcCtD
Methadone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000738	CcSEcCtD
Methadone—Tachycardia—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000736	CcSEcCtD
Methadone—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.27e-05	0.000735	CcSEcCtD
Methadone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000729	CcSEcCtD
Methadone—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.16e-05	0.000724	CcSEcCtD
Methadone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.09e-05	0.000719	CcSEcCtD
Methadone—Dizziness—Valsartan—type 2 diabetes mellitus	8.09e-05	0.000719	CcSEcCtD
Methadone—Anorexia—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000718	CcSEcCtD
Methadone—Clotrimazole—CYP2E1—type 2 diabetes mellitus	8.04e-05	0.0305	CrCbGaD
Methadone—Dizziness—Orlistat—type 2 diabetes mellitus	8e-05	0.00071	CcSEcCtD
Methadone—Asthenia—Metformin—type 2 diabetes mellitus	8e-05	0.00071	CcSEcCtD
Methadone—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	7.97e-05	0.0303	CrCbGaD
Methadone—Hypotension—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000704	CcSEcCtD
Methadone—Nausea—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000703	CcSEcCtD
Methadone—Pruritus—Metformin—type 2 diabetes mellitus	7.89e-05	0.0007	CcSEcCtD
Methadone—Urticaria—Losartan—type 2 diabetes mellitus	7.86e-05	0.000698	CcSEcCtD
Methadone—Abdominal pain—Losartan—type 2 diabetes mellitus	7.83e-05	0.000695	CcSEcCtD
Methadone—Body temperature increased—Losartan—type 2 diabetes mellitus	7.83e-05	0.000695	CcSEcCtD
Methadone—Vomiting—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000691	CcSEcCtD
Methadone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000688	CcSEcCtD
Methadone—Rash—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000685	CcSEcCtD
Methadone—Dermatitis—Valsartan—type 2 diabetes mellitus	7.71e-05	0.000685	CcSEcCtD
Methadone—Vomiting—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000683	CcSEcCtD
Methadone—Insomnia—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000682	CcSEcCtD
Methadone—Headache—Valsartan—type 2 diabetes mellitus	7.67e-05	0.000681	CcSEcCtD
Methadone—Clotrimazole—CYP1A2—type 2 diabetes mellitus	7.64e-05	0.029	CrCbGaD
Methadone—Diarrhoea—Metformin—type 2 diabetes mellitus	7.63e-05	0.000677	CcSEcCtD
Methadone—Rash—Orlistat—type 2 diabetes mellitus	7.63e-05	0.000677	CcSEcCtD
Methadone—Dermatitis—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000676	CcSEcCtD
Methadone—Atomoxetine—HTR2C—type 2 diabetes mellitus	7.62e-05	0.0289	CrCbGaD
Methadone—Headache—Orlistat—type 2 diabetes mellitus	7.58e-05	0.000673	CcSEcCtD
Methadone—Asthenia—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.00067	CcSEcCtD
Methadone—Somnolence—Ramipril—type 2 diabetes mellitus	7.55e-05	0.00067	CcSEcCtD
Methadone—Pruritus—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000661	CcSEcCtD
Methadone—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000655	CcSEcCtD
Methadone—Dizziness—Metformin—type 2 diabetes mellitus	7.37e-05	0.000654	CcSEcCtD
Methadone—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.29e-05	0.000648	CcSEcCtD
Methadone—Nausea—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000646	CcSEcCtD
Methadone—Constipation—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000644	CcSEcCtD
Methadone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.2e-05	0.000639	CcSEcCtD
Methadone—Nausea—Orlistat—type 2 diabetes mellitus	7.18e-05	0.000638	CcSEcCtD
Methadone—Propiomazine—HTR2C—type 2 diabetes mellitus	7.16e-05	0.0272	CrCbGaD
Methadone—Asthenia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000631	CcSEcCtD
Methadone—Vomiting—Metformin—type 2 diabetes mellitus	7.09e-05	0.000629	CcSEcCtD
Methadone—CYP3A5—nephron tubule—type 2 diabetes mellitus	7.08e-05	0.0217	CbGeAlD
Methadone—CYP2B6—nephron tubule—type 2 diabetes mellitus	7.04e-05	0.0215	CbGeAlD
Methadone—Alimemazine—CYP3A4—type 2 diabetes mellitus	7.03e-05	0.0267	CrCbGaD
Methadone—Rash—Metformin—type 2 diabetes mellitus	7.03e-05	0.000624	CcSEcCtD
Methadone—Dermatitis—Metformin—type 2 diabetes mellitus	7.02e-05	0.000623	CcSEcCtD
Methadone—Pruritus—Losartan—type 2 diabetes mellitus	7e-05	0.000622	CcSEcCtD
Methadone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000621	CcSEcCtD
Methadone—Headache—Metformin—type 2 diabetes mellitus	6.98e-05	0.00062	CcSEcCtD
Methadone—Dizziness—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000618	CcSEcCtD
Methadone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000616	CcSEcCtD
Methadone—CYP2C8—kidney—type 2 diabetes mellitus	6.9e-05	0.0211	CbGeAlD
Methadone—Trimipramine—ADRA2A—type 2 diabetes mellitus	6.81e-05	0.0258	CrCbGaD
Methadone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.77e-05	0.000601	CcSEcCtD
Methadone—Tamoxifen—ABCC2—type 2 diabetes mellitus	6.77e-05	0.0257	CrCbGaD
Methadone—Urticaria—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000599	CcSEcCtD
Methadone—Darifenacin—CYP3A4—type 2 diabetes mellitus	6.73e-05	0.0256	CrCbGaD
Methadone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000596	CcSEcCtD
Methadone—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000596	CcSEcCtD
Methadone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000594	CcSEcCtD
Methadone—Modafinil—CYP1A2—type 2 diabetes mellitus	6.68e-05	0.0254	CrCbGaD
Methadone—Rash—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000589	CcSEcCtD
Methadone—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000588	CcSEcCtD
Methadone—Nausea—Metformin—type 2 diabetes mellitus	6.62e-05	0.000588	CcSEcCtD
Methadone—Headache—Irbesartan—type 2 diabetes mellitus	6.59e-05	0.000585	CcSEcCtD
Methadone—Dizziness—Losartan—type 2 diabetes mellitus	6.55e-05	0.000581	CcSEcCtD
Methadone—CYP2B6—cardiovascular system—type 2 diabetes mellitus	6.32e-05	0.0193	CbGeAlD
Methadone—Vomiting—Losartan—type 2 diabetes mellitus	6.29e-05	0.000559	CcSEcCtD
Methadone—Trimipramine—HTR2C—type 2 diabetes mellitus	6.27e-05	0.0238	CrCbGaD
Methadone—CYP2C9—cardiovascular system—type 2 diabetes mellitus	6.26e-05	0.0191	CbGeAlD
Methadone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000555	CcSEcCtD
Methadone—Nausea—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000555	CcSEcCtD
Methadone—Rash—Losartan—type 2 diabetes mellitus	6.24e-05	0.000554	CcSEcCtD
Methadone—Dermatitis—Losartan—type 2 diabetes mellitus	6.24e-05	0.000554	CcSEcCtD
Methadone—CYP3A5—kidney—type 2 diabetes mellitus	6.23e-05	0.019	CbGeAlD
Methadone—Disopyramide—CYP3A4—type 2 diabetes mellitus	6.21e-05	0.0236	CrCbGaD
Methadone—Headache—Losartan—type 2 diabetes mellitus	6.2e-05	0.000551	CcSEcCtD
Methadone—CYP2B6—kidney—type 2 diabetes mellitus	6.19e-05	0.0189	CbGeAlD
Methadone—CYP3A5—pancreas—type 2 diabetes mellitus	6.18e-05	0.0189	CbGeAlD
Methadone—Asthenia—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000541	CcSEcCtD
Methadone—CYP19A1—liver—type 2 diabetes mellitus	6.09e-05	0.0186	CbGeAlD
Methadone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	6.06e-05	0.0185	CbGeAlD
Methadone—Pruritus—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000533	CcSEcCtD
Methadone—Nausea—Losartan—type 2 diabetes mellitus	5.88e-05	0.000522	CcSEcCtD
Methadone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000516	CcSEcCtD
Methadone—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	5.65e-05	0.0214	CrCbGaD
Methadone—Dizziness—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000498	CcSEcCtD
Methadone—CYP3A5—adipose tissue—type 2 diabetes mellitus	5.61e-05	0.0172	CbGeAlD
Methadone—Phenylbutazone—PTGS2—type 2 diabetes mellitus	5.53e-05	0.021	CrCbGaD
Methadone—Vomiting—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000479	CcSEcCtD
Methadone—Rash—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000475	CcSEcCtD
Methadone—Dermatitis—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000475	CcSEcCtD
Methadone—Headache—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000472	CcSEcCtD
Methadone—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	5.06e-05	0.0192	CrCbGaD
Methadone—Clotrimazole—CYP3A4—type 2 diabetes mellitus	5.06e-05	0.0192	CrCbGaD
Methadone—Nausea—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000448	CcSEcCtD
Methadone—CYP2C19—liver—type 2 diabetes mellitus	4.99e-05	0.0153	CbGeAlD
Methadone—Tamoxifen—CYP2E1—type 2 diabetes mellitus	4.75e-05	0.018	CrCbGaD
Methadone—ABCB1—islet of Langerhans—type 2 diabetes mellitus	4.67e-05	0.0143	CbGeAlD
Methadone—CYP3A4—kidney—type 2 diabetes mellitus	4.67e-05	0.0143	CbGeAlD
Methadone—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	4.64e-05	0.0176	CrCbGaD
Methadone—Orphenadrine—CYP2E1—type 2 diabetes mellitus	4.62e-05	0.0175	CrCbGaD
Methadone—CYP2D6—kidney—type 2 diabetes mellitus	4.6e-05	0.0141	CbGeAlD
Methadone—Tamoxifen—CYP1A2—type 2 diabetes mellitus	4.52e-05	0.0172	CrCbGaD
Methadone—Modafinil—CYP3A4—type 2 diabetes mellitus	4.42e-05	0.0168	CrCbGaD
Methadone—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	4.37e-05	0.0166	CrCbGaD
Methadone—CYP2C8—liver—type 2 diabetes mellitus	4.36e-05	0.0133	CbGeAlD
Methadone—Fentanyl—CYP3A4—type 2 diabetes mellitus	4.33e-05	0.0164	CrCbGaD
Methadone—Loperamide—CYP3A4—type 2 diabetes mellitus	4.17e-05	0.0158	CrCbGaD
Methadone—CYP1A2—liver—type 2 diabetes mellitus	4.08e-05	0.0125	CbGeAlD
Methadone—ABCB1—retina—type 2 diabetes mellitus	4e-05	0.0122	CbGeAlD
Methadone—CYP3A5—liver—type 2 diabetes mellitus	3.93e-05	0.012	CbGeAlD
Methadone—CYP2B6—liver—type 2 diabetes mellitus	3.91e-05	0.012	CbGeAlD
Methadone—CYP2C9—liver—type 2 diabetes mellitus	3.87e-05	0.0118	CbGeAlD
Methadone—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.84e-05	0.0146	CrCbGaD
Methadone—Atomoxetine—CYP3A4—type 2 diabetes mellitus	3.81e-05	0.0144	CrCbGaD
Methadone—ABCB1—nephron tubule—type 2 diabetes mellitus	3.76e-05	0.0115	CbGeAlD
Methadone—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	3.67e-05	0.0139	CrCbGaD
Methadone—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.38e-05	0.0103	CbGeAlD
Methadone—ABCB1—kidney—type 2 diabetes mellitus	3.31e-05	0.0101	CbGeAlD
Methadone—ABCB1—pancreas—type 2 diabetes mellitus	3.29e-05	0.01	CbGeAlD
Methadone—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.22e-05	0.00984	CbGeAlD
Methadone—Trimipramine—CYP3A4—type 2 diabetes mellitus	3.13e-05	0.0119	CrCbGaD
Methadone—Tamoxifen—CYP3A4—type 2 diabetes mellitus	2.99e-05	0.0114	CrCbGaD
Methadone—ABCB1—adipose tissue—type 2 diabetes mellitus	2.98e-05	0.00911	CbGeAlD
Methadone—CYP3A4—liver—type 2 diabetes mellitus	2.95e-05	0.00903	CbGeAlD
Methadone—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.91e-05	0.011	CrCbGaD
Methadone—CYP2D6—liver—type 2 diabetes mellitus	2.91e-05	0.00888	CbGeAlD
Methadone—ABCB1—liver—type 2 diabetes mellitus	2.09e-05	0.00639	CbGeAlD
Methadone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.65e-06	3.91e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.65e-06	3.91e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.64e-06	3.89e-05	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.63e-06	3.89e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.63e-06	3.88e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.63e-06	3.88e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.61e-06	3.86e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.61e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.61e-06	3.85e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.61e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.61e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.61e-06	3.85e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.6e-06	3.84e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.6e-06	3.84e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.6e-06	3.83e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.6e-06	3.83e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.59e-06	3.83e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.59e-06	3.83e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.59e-06	3.83e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.59e-06	3.82e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.58e-06	3.8e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.57e-06	3.79e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.55e-06	3.76e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.55e-06	3.76e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.55e-06	3.76e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.54e-06	3.74e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.53e-06	3.74e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.53e-06	3.73e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.5e-06	3.7e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.5e-06	3.69e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.49e-06	3.68e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.49e-06	3.68e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.47e-06	3.64e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.46e-06	3.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.45e-06	3.62e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.45e-06	3.61e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	3.61e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.44e-06	3.6e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.43e-06	3.59e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.42e-06	3.58e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.4e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.4e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.4e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.4e-06	3.55e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.4e-06	3.54e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.4e-06	3.54e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.39e-06	3.53e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.39e-06	3.53e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.39e-06	3.53e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.38e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.38e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.38e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.37e-06	3.5e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.36e-06	3.49e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.36e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.36e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.36e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.36e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.35e-06	3.47e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.34e-06	3.46e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.34e-06	3.46e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.34e-06	3.46e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.34e-06	3.45e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.33e-06	3.44e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.33e-06	3.44e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.32e-06	3.43e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.32e-06	3.42e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.32e-06	3.42e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.3e-06	3.39e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.29e-06	3.38e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.29e-06	3.38e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.28e-06	3.36e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.27e-06	3.36e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.27e-06	3.35e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.27e-06	3.35e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.27e-06	3.35e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.26e-06	3.34e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.26e-06	3.34e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.26e-06	3.33e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.25e-06	3.33e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-06	3.31e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.24e-06	3.31e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.23e-06	3.3e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.23e-06	3.29e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.23e-06	3.29e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.23e-06	3.29e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.21e-06	3.27e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.21e-06	3.26e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.21e-06	3.26e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.21e-06	3.25e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.21e-06	3.25e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.2e-06	3.25e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.19e-06	3.23e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.19e-06	3.23e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.18e-06	3.21e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.17e-06	3.2e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.14e-06	3.16e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.14e-06	3.16e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.13e-06	3.15e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.12e-06	3.13e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.12e-06	3.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.1e-06	3.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.1e-06	3.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.1e-06	3.1e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.1e-06	3.1e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.09e-06	3.08e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.08e-06	3.08e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.08e-06	3.07e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.07e-06	3.05e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.06e-06	3.04e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.06e-06	3.04e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.06e-06	3.04e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.05e-06	3.03e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.05e-06	3.03e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.04e-06	3.02e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.04e-06	3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.04e-06	3e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.03e-06	3e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.03e-06	3e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.03e-06	3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.03e-06	2.99e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.02e-06	2.98e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.02e-06	2.98e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2e-06	2.95e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2e-06	2.95e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2e-06	2.95e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.99e-06	2.94e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.99e-06	2.94e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.99e-06	2.93e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.98e-06	2.92e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.98e-06	2.92e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.97e-06	2.91e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.97e-06	2.91e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-06	2.88e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.95e-06	2.88e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.95e-06	2.87e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.95e-06	2.87e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.94e-06	2.86e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.93e-06	2.85e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.93e-06	2.85e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.93e-06	2.85e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-06	2.84e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.92e-06	2.84e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.92e-06	2.84e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.92e-06	2.83e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.91e-06	2.82e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.9e-06	2.8e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.9e-06	2.8e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.89e-06	2.79e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.87e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.87e-06	2.76e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.85e-06	2.74e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.85e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-06	2.73e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.84e-06	2.72e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.83e-06	2.71e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.82e-06	2.69e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.82e-06	2.69e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.82e-06	2.69e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.82e-06	2.68e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.81e-06	2.68e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.81e-06	2.67e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.81e-06	2.67e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.81e-06	2.67e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.8e-06	2.65e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-06	2.61e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.76e-06	2.6e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	2.58e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-06	2.58e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.74e-06	2.57e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.74e-06	2.56e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.72e-06	2.54e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.7e-06	2.51e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	2.5e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.68e-06	2.49e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.67e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.67e-06	2.47e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.67e-06	2.46e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.66e-06	2.45e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.64e-06	2.42e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.61e-06	2.38e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	2.36e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.59e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.58e-06	2.34e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.57e-06	2.32e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.57e-06	2.32e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	2.31e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.56e-06	2.31e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.56e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.56e-06	2.3e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.55e-06	2.29e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.55e-06	2.29e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.54e-06	2.28e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.54e-06	2.27e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.53e-06	2.26e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	2.26e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	2.25e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.5e-06	2.21e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.49e-06	2.2e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.49e-06	2.2e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-06	2.15e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-06	2.15e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.46e-06	2.15e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	2.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.43e-06	2.11e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.42e-06	2.1e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	1.41e-06	2.09e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.41e-06	2.09e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.4e-06	2.07e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.4e-06	2.06e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.37e-06	2.03e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.37e-06	2.03e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.37e-06	2.02e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.36e-06	2.01e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.35e-06	2e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.34e-06	1.98e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.97e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.33e-06	1.96e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.29e-06	1.91e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.29e-06	1.9e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.26e-06	1.86e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	1.85e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.25e-06	1.84e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.81e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.22e-06	1.81e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.22e-06	1.8e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.2e-06	1.78e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.2e-06	1.77e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.19e-06	1.76e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	1.75e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-06	1.72e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-06	1.72e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	1.57e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	1.54e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	1.51e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.39e-07	1.39e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	9.08e-07	1.34e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.98e-07	1.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.98e-07	1.33e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	8.88e-07	1.31e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.21e-07	1.21e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	7.69e-07	1.13e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.86e-07	1.01e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.7e-07	9.89e-06	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.31e-07	9.32e-06	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.26e-07	9.24e-06	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.35e-07	7.89e-06	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.13e-07	6.09e-06	CbGpPWpGaD
